Location of Centers Participating in the CIBMTR 2014 Annual Number of Transplant Recipients in the US by Transplant Type Transplant Recipients in the US by Transplant and Donor Type Cumulative Plot of Transplant Recipients in the US by Transplant Type ID: 774798
Download Presentation The PPT/PDF document " Current Uses and Outcomes of Hematopoie..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Current Uses and Outcomes of Hematopoietic Stem Cell Transplantation
Slide2Location of Centers Participatingin the CIBMTR 2014
Slide3Annual Number of Transplant Recipients in the US by Transplant Type
Slide4Transplant Recipients in the US, by Transplant and Donor Type
Slide5Cumulative Plot of Transplant Recipients in the US by Transplant Type
Slide6Stem Cell Sources for Allogeneic Transplants by Year
Slide7Trends in Autologous Transplants by Recipient Age*
Slide8Trends in Allogeneic Transplants by Recipient Age*
Slide9Indications for Hematopoietic Stem Cell Transplants in the US, 2012
Slide10Allogeneic Transplants in Patients ≤ 20 Years, Registered with the CIBMTR
Slide11Allogeneic Transplants for Age > 20 years, Registered with the CIBMTR
Slide12Causes of Death after Autologous Transplants done in 2011-2012
Slide13Causes of Death after HLA Match Sibling Transplants done in 2011-2012
Slide14Causes of Death after Unrelated Donor Transplants done in 2011-2012
Slide15Allogeneic Transplants Registered with the CIBMTR
Slide16Survival after HLA Match Sibling Donor Transplants for AML, 2002-2012
Slide17Survival after Unrelated Donor Transplants for AML, 2002-2012
Slide18Survival after HLA Match Sibling Donor Transplants for AML, Age < 20 Years, 2002-2012
Slide19Survival after Allogeneic Transplantsfor MDS, 2002-2012
Slide20Survival after Allogeneic Transplantsfor MDS, 2002-2012
Slide21Survival after HLA Match Sibling Donor Transplants for ALL, Age < 20 Years, 2002-2012
Slide22Survival after Unrelated Donor Transplants for ALL, Age < 20 years, 2002-2012
Slide23Survival after HLA Match Sibling Donor Transplants for ALL, Age ≥ 20 Years, 2002-2012
Slide24Survival after Unrelated Donor Transplants for ALL, ≥ 20 Years, 2002-2012
Slide25Survival after HLA Match Sibling Transplants for CML, 2002-2012
Slide26Survival after Allogeneic Transplants for CLL, 2002-2012
Slide27Survival after Allogeneic Transplants for Severe Aplastic Anemia, < 20 Years, 2002-2012
Slide28Survival after Allogeneic Transplants for Severe Aplastic Anemia, ≥ 20 Years, 2002-2012
Slide29Survival after Autologous Transplants for Hodgkin Lymphoma, 2002-2012
Slide30Survival after Allogeneic Transplants for Hodgkin Lymphoma, 2002-2012
Slide31Survival after Autologous Transplants for Follicular Lymphoma, 2002-2012
Slide32Survival after Allogeneic Transplants for Follicular Lymphoma, 2002-2012
Slide33Survival after Autologous Transplants for DLBCL, 2002-2012
Slide34Survival after HLA Match Sibling Transplants for Diffuse Large Cell Lymphoma, 2002-2012
Slide35Survival after Transplants for Mantle Cell Lymphoma, 2002-2012
Slide36Survival after Transplants for Multiple Myeloma, 2002-2012